Two Months or Ten Years? How much new cancer drugs really extend life
You've probably seen the claim that new cancer drugs extend life by only about 2.1 months on average. I fact-checked it against the original studies and added the evidence published since 2014. Short version: the number is real, but it describes the typical drug, not the best ones.
What holds up
- The 2.1-month figure (Fojo et al., 2014) is accurate as a median across 71 FDA solid-tumor approvals from 2002–2014.
- Newer reviews confirm it hasn't budged: 2.40 months (2000–2016), 2.55 months (2000–2020), 2.42 months (Swiss approvals, 2001–2020). Of 31 drugs approved 2000–2016 with median survival data, only one added more than six months.
- Classic example: erlotinib in pancreatic cancer improved median survival from 5.91 to 6.24 months, about 10 days.
- Drugs that later fail to show a survival benefit often stay on the market at premium prices, and most patients with metastatic lung or colorectal cancer don't realize their chemo is very unlikely to cure them.
What's misleading
- Those drugs were mostly targeted therapies and biologics, not classic chemotherapy.
- A median can't show long-term survivors. In advanced melanoma, nivolumab plus ipilimumab produced a median survival of 71.9 months versus 19.9 months, and 43% of patients were alive at ten years.
- Real benefits show up in national statistics. US non-small cell lung cancer deaths fell sharply after 2013, when mutation testing and matched targeted drugs became standard. Small cell lung cancer, with no comparable drugs, saw no survival improvement.
The catch
The big winners help a limited group. More than half of US patients with advanced cancer are now eligible for immunotherapy, but only about one in five responds. Mutation-matched drugs reach about 7% of patients as responders. Both figures are best-case estimates.
Bottom line: most new approvals are marginal, while a small minority are transformative for specific tumors and biomarker-defined patients. The useful question isn't "how much do cancer drugs help?" but "which group does this drug, for this tumor, belong to?"
The full post, with a claim-by-claim fact-check table, a chart and 16 linked references:
👉 https://synergiesforcancertreatments.blogspot.com/2026/09/two-months-or-ten-years.html
